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SUMMARY 
 
Bone marrow-derived mesenchymal stromal cells (BM-MSC) are stromal precursors 
endowed with extensive immunomodulative properties. In this study, we aimed to 
assess whether Toll-like receptor(TLR)3- and TLR4-activated BM-MSC influence 
human neutrophil responses under coculture conditions. We show that TLR3 triggering 
by poly(I:C) dramatically amplifies, in a more significant manner than TLR4 triggering 
by LPS, the antiapoptotic effects that resting BM-MSC constitutively exert on 
neutrophils under coculture conditions. In addition, TLR3- and TLR4-activated BM-
MSC enhance respiratory burst ability and CD11b expression by neutrophils. The 
coculture in the absence of cell contact and the incubation of neutrophils in supernatants 
harvested from TLR3- and TLR4-activated BM-MSC yield comparable results in terms 
of increased survival and immunophenotypic changes, thus suggesting the involvement 
of endogenous soluble factors. Neutralizing experiments reveal that the biological 
effects exerted on neutrophils by TLR3-activated BM-MSC are mediated by the 
combined action of IL-6, IFN- and GM-CSF, while those exerted by TLR4-activated 
BM-MSC mostly depend on GM-CSF. MSC isolated from thymus, spleen and 
subcutaneous adipose tissue behave similarly.  
Therefore, our data highlight a novel mechanism by which MSC sustain and amplify the 
functions of neutrophils in response to TLR3- and TLR4-activation and may 
consequently contribute to inflammatory disorders.  
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INTRODUCTION 
 
TOLL-LIKE RECEPTORS: 
 
Definition and characterization 
Toll-like receptors (TLRs) are transmembrane receptors mediating the activation 
and functions of several cells of the innate and acquired immune system, including 
polymorphonuclear (PMN) neutrophils
1-3
. By recognizing highly-diffused pathogen-
associated molecular patterns (PAMPs) present in viruses, bacteria and other pathogens, 
they provide a fundamental trigger for early inflammation and the subsequent immune 
response. 
 
Originally, TLRs were discovered by means of mouse mutants (and a classic 
genetic approach) as the homologues in mammals of Drosophila Toll molecule
4-5
. In 
fruitflies, Toll was initially identified as one of the genes responsible for the 
differentiation of ventral and dorsal structures during embryo development
5
; as later 
studies have demonstrated, it is actually a very ancient, phylogenetically conserved 
molecule modulating also the interactions of cells with their microenvironment and, 
especially, the initial response to pathogens (e.g. in Drosophila, fungal infections)
6
. 
Their homologues can be found in plants, as well, where several disease resistant genes 
encode proteins characterized by the presence of the Toll/IL-1 receptor intracellular 
domain (TIR), typical of both TLRs and members of the IL-1R family. Their precise 
mechanisms of function in plants, however, are very different from animals, and largely 
still unknown
7
. In mammals, Toll-like receptors are not involved in embryo 
development, as mice lacking TLR4 develop normally
2,7
. Instead, they belong to the 
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family of pathogen-associated molecular patterns (PAMP)-recognizing receptors, 
capable of activating several cells of the innate immune system in recognition of 
molecular patterns featured by non-self, potentially dangerous organisms
4,8-10
. 
 
Structurally, TLRs shows high similarity with that of the IL-1 receptor family: 
their cytoplasmic portion, i.e. the TIR domain, originates from a common genetic 
precursor. Despite this shared evolution, though, the extracellular part of the two is 
unrelated, as TLRs bear leucine-rich repeats (LRRs), while IL-1 receptors possess an Ig-
like domain
4,8
. TLRs are functional multimers: most of them are homomeric, but some 
are instead heteromeric, e.g. TLR2, which strictly associates with TLR1 or TLR6. 
TLR4, finally, forms even more complex structures together with coreceptors, such as 
CD14 and the LPS-binding subunit MD2
2,4,8
.  
Ten different TLRs have been discovered, so far, in humans (Figure 1)
11
; each 
of them is characterized by sensitivity to specific molecular patterns easily found in 
pathogens
10
. Overall, TLRs that are usually exposed on the surface of the cells, i.e. 
TLR1, -2, -4, -5, -6 are sensitive to bacterial-derived molecules, such as either bacterial 
lipoproteins and lipoteichoic acids (LTA) (TLR1/TLR2 and TLR6/TLR2), or LPS 
(TLR4), or flagellin (TLR5)
7,10
. TLRs more commonly present in the cell cytoplasm, 
i.e. TLR3, -7, -8, -9 are usually responsible for reactions to molecules derived from 
intracellular pathogens and viruses, such as double-stranded RNA (TLR3), single-
stranded viral RNA (TLR7 and -8), or unmethylated CpG DNA fragments (TLR9)
7-10
. 
No specific ligand for TLR10 has been identified, as yet. 
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FIGURE 1. Toll-like receptors in humans.  
TLR1 TLR2
TLR6 TLR2
TLR5 TLR7
TLR8
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Triacylated lipoprotein / LTAs
Diacylated lipoprotein
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Imidazoquinolines
CpG DNA
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poly(I:C)
dsRNA
MD-2
MyD88-dependent pathway TRIF
(MyD88-independent pathway)
(modified from Takeda et al., 2004)  
All Toll-like receptors (TLR) recognize molecular pattern present in microbial components. TLR2 
works in heterodimers together with either TLR1 or TLR6 for the recognition of microbial 
lipopeptides and licotheicoic acids (LTAs). TLR4 recognizes lipopolysaccharides (LPS), together 
with mediators such as MD-2 or co-receptors such as CD14 (not shown). TLR3 and TLR9 recognize 
viral-related nucleic acids sequences, i.e. double-stranded RNA (dsRNA) and CpG DNA, 
respectively. TLR5 is the receptor for flagellin. All TLRs exept TLR3 activate the MyD88-
dependent pathway through the coupling protein MyD88. TLR3 and, partially, TLR4 act 
downstream by a MyD88-independent pathway which uses TRIF (TIR-domain containing adaptor 
inducing IFN-) as primary coupling protein. 
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TLRs are widely expressed by the main cells of the innate and adaptive immune 
system, including monocyte/macrophages
9-10
, polymorphonuclear leukocytes
1,3
, 
dendritic cells
12-14
, T and B lymphocytes
13,15-17
, NK cells
16
. In all vertebrates, and 
particularly in mammals, TLRs are deeply involved in the far more complex 
mechanisms that enable the discrimination of the self from non-self by the immune 
system
2
. In fact, their activation during organ transplantation can prevent the 
development of immune tolerance towards the transplant
18
. In monocytes, and in most 
leukocytes, as well, their challenge by adequate stimuli results in the activation of the 
defensive mechanisms provided by the cells and in the release of cytokines, chemokines 
and other powerful proinflammatory mediators. Although TNF-, IL-1 and IL-6 are 
usually cited as example, chemokine genes actually show the strongest gene induction 
upon TLR triggering
7
. 
Besides their PAMP-recognizing abilities, TLRs also serve other very different 
functions depending on the cell types which express them
9-10
. For instance, TLR3, 
besides being a typical “intracellular” TLR, is expressed both intracellularly and on the 
cell surface by human fibroblasts, epithelial cells
19-20
 and human mesenchymal stromal 
cells
21-23
, where it promotes various functions, mostly related to cell sensitivity to 
microenvironmental changes and the triggering of defensive responses, but still largely 
unknown. Epithelial cells at potential sites of entry, including the skin and the 
respiratory, intestinal and genitourinary tracts, all express TLRs, again with very 
different cell-specific functions
7
. Endothelial cells and vascular smooth muscle cells, for 
instance, are sensitive to potential infective agents by their own TLRs, and, in the 
presence of signs of an infection, mediate the very early defense by switching capillary 
networks to a proinflammatory phenotype
24
.  
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Further increasing the overall complexity of TLR networks, it is worth to note 
that the expression pattern of TLRs can in some cases vary even when considering the 
same cell type: for instance, monocytes and tissue macrophages can significantly up- or 
downregulate their expression of TLRs and, thus, their sensitivity to stimuli depending 
on the conditions of the microenvironment and the presence of cytokines, chemokines 
and other pro-inflammatory molecules
7
. 
TLRs also serve as an important link between innate and adaptive immunity 
through actions on T cells
15,25-26
 and particularly on dendritic cells
14-15
. DC maturation 
into active antigen-presenting cells (APCs), capable of exerting a proper T cell 
response, is highly dependent on TLR stimulation by pathogen-derived molecules 
acquired by phagocytosis
14
. Moreover, TLR3 activation on several cell types results in 
highly efficient type-I interferon (IFN-/) production. Besides their antiviral 
properties, both interferons play an important role in many phases of a typical immune 
response, such as the proliferation of memory T cells, the inhibition of T cell apoptosis, 
the secretion of IFN- and the differentiation of B cells into plasma cells15. Finally, IFN-
 and IFN- also modulate the activation of NK cells15. 
 
Even though TLRs are primarily thought to have evolved as sensors of 
exogenous stimuli, several endogenous ligands have been characterized, especially in 
paraphysiological and pathological conditions. They may represent products from 
damaged host cells, but are still unknown in many cases. A potential example are small 
pieces of repetitive mRNA released from necrotic tissue and folded in short double-
stranded sequences, which have been demonstrated to be able to activate TLR3 in 
several mouse models of enterogenic sepsis
27-28
. In these animals, TLR3 activation 
occurs in the absence of exogenous viral stimulus, and the block of its signaling, 
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obtained either by using TLR3-deficient mice or by neutralizing anti-TLR3 mAbs, was 
associated with significantly lower levels of tissue injury and lower sepsis-induced 
mortality
28
. 
Besides necrotic mRNA, other potential endogenous ligands for TLRs (reviewed 
in Parker et al.
7
) include: antimicrobial molecules such as defensins (recognized by 
TLR2); the high mobility group box 1 (HMGB1) protein (a potential ligand for both 
TLR2 and TLR4); proteins from damaged tissue, such as heat-shock protein B8, 
fibrinogen, surfactant protein A (all sensed by TLR4); products of tissue matrix 
digestion, such as fibronectin extra domain A and hyaluronic acid oligosaccharides (via 
TLR4). TLR2 has shown sensitivity also to reactive oxygen species, and oxydative 
stress was demonstrated to influence cardiomyocyte behaviour via TLR2
29
.  
Despite this, in many cases, regardless of consistent evidence of TLR activation 
in the course of several diseases, the actual endogenous trigger responsible for it in vivo 
is still unidentified. One such example is asthma: TLRs play a crucial role in the 
development and worsening of the disease, as contaminating endotoxin is routinely 
inhaled with air, and TLRs are expressed either in tissue-resident epithelial cells and 
alveolar macrophages, as well as in airways-infiltrating monocytes and bronchial 
smooth muscle cells
30
. By acting on TLRs sensitivity, viruses like respiratory syncytial 
virus (RSV) and influenza A can significantly worsen asthma, along with other 
respiratory diseases. For instance, sensitization to viral and bacterial products, a 
common consequence of viral infections in asthmatic patients, occurs via up-regulation 
of TLR3 and -4 in several types of bronchial cells
31-32
. 
Another example of diseases involving TLR activation in their pathogenesis, 
even without clearly identified endogeneous ligands, is cancer. TLR signaling has been 
investigated as pivotal in the development of a chronic inflammatory process leading up 
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to gastrointestinal cancer in its early stages
33
, as well as in the development of 
chemoresistance by different types of malignancies
34-35
. At the same time, the cytokines 
produced, as a consequence of TLR stimulation, by either tumor-associated stromal 
cells and tumor-infiltrating leukocytes have been addressed as powerful inducers 
favouring tumoral growth. This may happen by direct effect
35-38
 or indirectly, by the 
formation of a local immunosuppressive environment serving as sanctuary against the 
antineoplastic immune reaction
35,39-41
. 
Therefore, the actual role of TLRs in both physiological and pathological 
conditions is far more complex than their function as sensors of exogeneous threats, and 
has not been fully understood yet. 
 
TLR signaling 
Signaling after TLR activation depends on a cascade of molecular events. As 
TLRs share with the IL-1 receptor family the intracellular TIR domain, their molecular 
cascade was expected to be similar, at least in the first phase. In fact, the interaction of 
MyD88 with TLRs (or IL-1R) accounts for the initiating event in both cases. 
MyD88 is a coupling protein characterized by a TIR domain in the C-terminal 
portion, and a death domain in the N-terminal portion
4,8
. Through the death-domain of 
MyD88, TLRs recruit IL-1 receptor-associated kinases (IRAKs), which carry the signal 
forward (Figure 2). Of the four members of this family, only IRAK-1 and -4 are the 
ones catalytically active, while the other two (IRAK-2 and IRAK-M) function as 
regulators
11,42
. It was recently shown how IRAK-4 actually acts upstream of IRAK-1
43
, 
ans, as such, is more important than IRAK-1 in transmitting the signal. Unsurprisingly, 
IRAK-4 deficiency is associated with a substantial increase in the incidence of pyogenic 
bacterial infections in humans
44
. 
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IRAK-4 and IRAK-1, activated by phosphorylation, associate with TRAF6 
(TNF-receptor-associated factor-6), a common mediator capable of activating both 
JNK and NF-kB transcription factors downstream. The IRAK-1/TRAF6 complex 
physically dissociates from the TLR and interacts at the internal membrane portion with 
TGF--activated kinase 1 (TAK1) and TAK1-binding proteins (TAB1 and TAB2). This 
large complex then moves in the cytoplasm, where it interacts with other proteins, such 
as the E2 ligases Ubc13 and Uev1A, that mediate the interaction between TRAF6 and 
TAK1, and finally the activation of NF-kB by phosphorylation of its IkB inhibitory 
fraction. Alternatively, the TRAF6/TAK1 complex can activate the AP-1 transcription 
factor by the MAP-kinase signaling proteing JNK (Figure 2)
11
. 
 
While the MyD88-dependent signaling pathway was first discovered as common 
to all TLRs exept TLR3, an alternative MyD88-independent pathway was identified 
later as exclusive to TLR3, and, to a lesser extent, TLR4
45
 (Figure 3). It appeared 
crucial in determining the production of interferon- (IFN-) in several cell types in 
response to both natural and synthetic double-stranded RNAs
46-47
. As a matter of fact, 
much before TLR3 was discovered, its principal ligand, synthetic poly(I:C), had already 
been identified as a very powerful inducer of IFN-. Following TLRs characterization, 
the existence of an alternative signaling pathway independent from MyD88 was 
hypothesized after experiments with the  mouse mutant strains C3H/HeJ. These mutants 
are characterized by a point mutation in the gene codifying the TIR domain that results 
in the substitution of Proline with Histidine in position 712 of the protein. As such, their 
TLRs lack the interaction with MyD88 and its downstream signaling pathway
48
. 
Nonetheless, also in these mutants it was possible to observe interferon production after 
TLR3 triggering, and there still was a partial, delayed activation of NF-kB and JNK 
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FIGURE 2. TLR-mediated MyD88-dependent signaling pathway. 
TLR
MyD88
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Upon stimulation, IRAK-4, IRAK-1 and TRAF6 are recruited to the receptor. Activated TRAF6 
then interacts with TAK1, TAB1 and TAB2 to form a cytoplasmic signaling complex. 
Phosphorylated TAK1 further activates NF-kB and AP1 transcription factors via IKK complex (not 
shown) and JNK (MAP kinases), respectively. 
 
 
FIGURE 3. TLR-mediated MyD88-dependent signaling pathway. 
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Exclusive to TLR3 and TLR4 signaling, the MyD88-independent signaling pathway leads to 
activation of IRF-3 via TRIF, TBK1 and IKKe/IKKi. The subsequent IFN- production lead to 
phosphorylation of Stat-1 and several IFN-inducible genes. 
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in monocytes after challenging with LPS (the main TLR4-ligand).  
These observations were later confirmed by studies in MyD88 knockout mice. In 
both cases, none of the pro-inflammatory cytokines typically produced in wild-type 
mice after TLR activation was observed. On the contrary, MyD88 independent pathway 
activated the Interferon-Regulatory Factor (IRF)-3 and by that acted on IFN- 
production, resulting in the phosphorylation of Stat1 by interferon, and ultimately in the 
induction of several IFN-inducible genes, such as IP-10 and GARG16
45,49-52
 (Figure 3). 
This was evident after TLR3 stimulation in both wild-type and MyD88 knockout mice, 
while it was observed after TLR4 triggering only in MyD88 knockout cells
50,52
.  
In fact, the effective importance of this pathway in determining the effects of 
TLR4 triggering in physiological conditions is still unclear: for instance, TLR4 
stimulation does not result in IFN- production via mobilization of the MyD88-
independent signaling pathway in human neutrophils
53
. Therefore, there may be 
significant differences at this regard between humans and mice, and depending on the 
cell types under investigation. 
IRF-3 activation in the MyD88-independent pathway follows interaction of 
TLR3 and TLR4 with TIR-domain adaptor inducing IFN- (TRIF), which serves as 
alternative coupling protein in the absence of MyD88
54
 (Figure 3). In fact, all TLR 
signaling can be abolished by two mutations (in genes encoding MyD88 and TRIF)
2
. 
TRIF, by interacting with IKKe and IKKi, can activate TBK1 and, in turn, NF-kB, thus 
explaining the modest level of NF-kB activation that was observed in early experiments 
with MyD88 knockout cells challenged with LPS
11,54
. In any case, these two pathways 
appear quite distinct, as the role their activation plays in in vivo situation: while TLR3 
activation by double-stranded RNA ultimately results in IFN- production and the 
development of an anti-viral response by MyD88-independent signaling, all the other 
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TLRs, mainly responsive to extracellular pathogens and bacteria, result in the outburst 
of proinflammatory cytokines driving the early phase of the inflammatory response. 
 
Signaling by TLRs has several internal modulators: for instance, an alternatively 
spliced variant of MyD88, lacking the intermediate domain and inhibiting LPS-induced 
NF-kB activation, is produced in response to prolonged LPS stimulation
43
. An 
additional TIR-domain containing adaptor, TIRAP/Mal, has been shown to mediate the 
interaction between MyD88 and IRAKs. The role of other molecules, such as Toll-
interacting protein (Tollip) and members of the Pellino family, is still disputed
11
. 
Finally, TRIF knockout mice showed a defective TLR4-mediated production of  
inflammatory cytokines, even though the MyD88-dependent pathway was unaffected by 
the mutation. This led to the speculation that TLR4 pathway actually requires activation 
of both MyD88-dependent and -independent pathways to function properly in 
physiological conditions
11
. Interestingly, TLR4 activated by lipid A in the absence of 
CD14 triggers the MyD88-dependent pathway with no influence on the alternative 
TRIF pathway
11
. 
 
TLR4 functions in human neutrophils 
Neutrophils play an essential role in the response to infections by the innate 
immune system (Figure 4). They represent almost two thirds of circulating leukocytes 
and they rapidly react to the threat posed by an exogenous infection, or tissue damage, 
by migrating to the site of damage, by limiting infection and by recruiting other immune 
cells through the release of a wide variety of inflammatory cytokines, chemotactic 
molecules and antimicrobial products
55
. In most cases, this results in pathogen clearance 
and/or the initiation of the adaptive immune reaction
55-56
. Excessive or inappropriate 
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neutrophil activation, on the other hand, is a pathogenetic step in most autoimmune 
diseases, such as rheumatoid arthritis, but also inflammatory bowel disease, asthma, 
chronic obstructive pulmonary disease, all characterized by an on-going excessive 
inflammation, and acute respiratory distress syndrome, the pulmonary equivalent of 
systemic sepsis
55,57-58
.  
Human neutrophils express mRNA for all the TLRs, except TLR3
1,3,53
. They 
react to the specific ligands of all TLRs, except poly(I:C) (the typical TLR3-ligand)
3
. 
CpG DNA (a powerful TLR9 trigger) requires the pretreatment of neutrophils with GM-
CSF to elicit a response
3
. In line with the objects of the present work, we will 
concentrate on neutrophil activation by LPS, the specific TLR4-ligand
59
. 
Neutrophil activation by TLRs involve almost exclusively the MyD88-
dependent pathway, and a large amount of data are available from the literature on the 
possibility to activate NF-kB
60
 and MAPK signaling
61
 following challenge with LPS. 
The effective role played by the MyD88-independent pathway in neutrophils is still 
debated, and probably not so significant as previously thought: although LPS can elicit 
via TLR4 the induction of several antiviral genes in neutrophils, and the mobilization of 
MyD88 independent signaling
62
, experiments performed with highly purified 
preparations, devoid of monocytes, seem to indicate that this mechanism does not 
involve the production of IFN-, nor the autocrine IFN-activating loop observed e.g. 
in monocytes
53,62
. Further complicating the picture, the response elicited on JNK 
activation by TLR4 triggering may be different depending on the fact that neutrophils 
are kept in suspension or in adherence to a substrate
63
; how much this influences 
neutrophil response in an in vivo context is still debated, but JNK activation is necessary 
in neutrophil to release the chemokine monocyte chemoattractant protein-1, important 
for monocyte recruitment, and may therefore have a role in the cross-talk between 
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FIGURE 4. Origin and differentiation of polimorphonuclear neutrophils. 
 
A. schematic differentiation of a PMN neutrophil from a Hematopoietic Stem Cell. B. Schematic 
representation of the three types of PMN (granulocytes), as they appear after May-Grunwald-
GIEMSA staining. C-D: morphological bone marrow smears after May-Grunwald-GIEMSA 
staining: the arrow indicates a promyelocyte, while asterisks indicate early neutrophils. Various 
neutrophils at complete differentiation are seen in the field. E-G: fully-differentiated neutrophils in 
a morphological smear of peripheral blood. H: a mature eosinophil from the same smear. 
Magnification: C-D: 200x (scale bar = 80 m); E-H: 300x (scale bar = 10 m). 
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these cell types during inflammation
63
. 
 
TLR triggering by PAMPs induces responses in a variety of cells in vivo, 
primarily epithelial cells, endothelial cells, and  monocytes/macrophages. Activation of 
these cells by TLRs may indirectly drive neutrophil migration, e.g. by modulating the 
expression of endothelial adhesion molecules. At the same time, it may result in the 
selective recruitment of neutrophils in specific danger zones, e.g. by cytokine and 
chemokine production
1
.  
TLRs modulate neutrophil migration and activation by many different 
mechanisms. First, an indirect mechanism has been proposed, by which TLR4 
triggering results in the down-regulation of G-protein receptor kinase, responsible for 
the desensitization of CXCRs to their ligands, and therefore determines an enhanced 
sensitivity of neutrophils to chemotactic stimuli
64
. Then, TLR4 engagement by LPS 
results in delayed neutrophil apoptosis
3,65-66
, increased L-selectin shedding and the 
upregulation of several adhesion molecules, e.g. CD11b
66
. Finally, many inflammatory 
mediators, present at sites of infection, regulate neutrophil chemokine receptors and, 
therefore, their additional chemiotaxis. 
While enhancing migration ability, TLRs also play a pivotal role in the 
establishment of a local inflammatory infiltrate. In fact, once localized, neutrophils 
loose much of their migration ability: LPS-activated neutrophils progressively loose IL-
8-binding capacity, as well as down-regulate IL-8Rs
3,67
 and CXC chemokine receptor 
(CXCR)-1 and -2
68
. Among these, CXCR2 is known to play a pivotal role in neutrophil 
recruitment, and to be directly downmodulated after TLR4 stimulation
1
. These 
combined actions help stabilize neutrophils where they are needed to exert an effective 
defense.  
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Once localized, neutrophils act against pathogens by phagocytosis and by the 
generation of large amounts of reactive oxygen intermediates, cytokines and 
chemokines
69
. Neutrophil sensitivity to local pathogens, as well as many of the features 
of activated neutrophils, depend on TLRs
3,9-10,62
: among them, LPS seems to have a 
pivotal role in priming neutrophils to enhanced respiratory burst ability
3,66
, but TLR-
stimulated neutrophils have also shown increased phagocytosis of opsonized targets
3
. 
TLR2 is also a crucial neutrophil activator, without the strict requirements of serum (i.e. 
LPS binding proteins) or CD14 to elicit its own response
1
. Studies with selective 
agonists have tried to dissect TLR4- from TLR2-dependent effects; these have been 
further complicated, until recently, by the technical difficulties existing in obtaining 
highly purified neutrophil preparations, as well as by the frequent presence of traces of 
contaminants in commercially-available LPS batches
1
. In experiments that took these 
issues into account, TLR2 and TLR4 appeared to induce a very similar activated state in 
neutrophils. To date, the only significant difference between the two has been observed 
with regard to survival and the generation of reactive oxygen intermediates, which both 
appear more effectively increased by TLR4 triggering than TLR2
66,70
; the difference, 
however, is merely quantitative. Interesting enough, both these studies confirmed the 
direct role of LPS in arresting early apoptosis (4h), by activation of the MyD88-
dependent pathway; they did not confirm, though, earlier observations that indicated a 
prolonged neutrophil survival, up to 22h, following LPS stimulation. Instead, this was 
explained by the presence of contaminating monocytes in earlier studies
66,70
. Thus, it is 
currently thought that TLR4 activation on neutrophils by LPS alone results in a a direct, 
yet temporally-limited, delay of spontaneous apoptosis
1
. 
In summary, TLR4 activation by LPS is the first step in a complex network of 
alterations that ultimately powerfully affect neutrophil viability, trafficking, migration, 
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adhesion to inflamed endothelia and function as tissue infiltrate. All these actions 
cooperate in providing a powerful inflammatory response against infections. 
 
MESENCHYMAL STROMAL CELLS 
 
Definition and characterization 
Multipotent mesenchymal stromal cells (MSC), formerly known as mesenchymal 
stem cells, are the precursors of tissue stromal cells and fundamental elements of tissue 
homeostasis
71-73
. Originally isolated from the bone marrow (BM) as nurse cells for the 
committed hematopoietic lineages and part of the hematopoietic niche
74-75
, MSC can be 
expanded from virtually all tissues
76
, including peripheral blood
77
, and thus form a 
complex stromal system throughout the body. Although the real in vivo counterpart of 
culture-expanded MSC still remains a matter of debate, after a decade of intense 
research much is known about their in vitro characteristics and the protocols to isolate 
and successfully expand them
78
. According to the definition criteria adopted by The 
International Society for Cellular Therapy (ISCT) MSC have to show a homogeneous 
immunophenotype after short in vitro culture (passage 2-3); they express a minimal 
panel of mesenchymal markers (e.g. CD106, CD90, CD44, CD29), without evidence of 
hematopoietic (e.g. CD34, CD45, CD117/c-kit) or endothelial (e.g. CD31, vWF) 
differentiation; they undergo clear multipotent differentiation in at least three 
differentiated progenies of the same embryonal layer (mostly adipocytes, osteoblasts 
and chondrocytes) after exposure to specific induction media
79
. International consortia 
have been formed to standardize the procedures for cell collection, culture and tests 
prior to clinical use in large international trials of regenerative medicine
80
.  
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Among other functions, MSC display powerful immune modulatory properties 
towards the main immune effector cells
81-83
. The activation of T-lymphocytes by either 
TCR-dependent
84
 or unspecific stimuli
85
 is prevented by BM-MSC under in vitro 
coculture conditions; such effects are mediated by redundant mechanisms depending on 
both contact-dependent interactions
84
 and soluble factors
83-84
, and their effect is 
pleiotropic. MSC also positively or negatively affect B-cell proliferation, according to 
their priming by inflammatory cytokines
86-88
, and they may inhibit NK
81,89
 and dendritic 
cell reactivity towards allogeneic cells
81,90
. In addition, they significantly interact with 
monocytes and macrophages in vitro and in vivo; their administration in a mouse model 
of enterogenic sepsis has lowered inflammation and improved survival through the 
prostaglandin E2-dependent modulation of monocytic IL-10 production
91
.  
Overall, MSC and their progeny
92 
seem to act as a competitive system that 
prevents excessive reactions towards pathogens, thus contributing to the resolution of 
immune responses
82-83
. MSC immune modulatory properties have been demonstrated 
also in vivo
93
, where they appear to be finely tuned by the local microenvironment
82-83
. 
For instance, inflammatory cytokines, such as IFN- or TNF-, “prime” MSC for 
enhanced suppressive mechanisms
94
, while infectious agents may hamper MSC 
inhibitory effects towards lymphocytes and other cell types through the engagement of 
Toll-like receptors (TLRs), such as TLR3 and TLR4
21
.  
 
Role of TLR3 and TLR4 on Mesenchymal Stromal Cells 
Expression of mRNAs for TLRs in BM-MSC has been assessed by many 
different studies
21-23
: of the ten receptors known in humans, only TLR2, -3 and -4
21-22
 
have proved to be expressed at high level (as mRNA), and to be functionally present as 
proteins on the surface of MSC
21-23
. TLR1, TLR5, TLR6, on the other hand, are 
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expressed at low level as mRNA only
21-22,95
. TLR9 was detected as mRNA, but not as 
functional protein, in adipose-tissue derived MSC
95
, while, by contrast, a more recent 
publication reported constitutive expression of TLR9 by resting human BM-MSC, and 
increased tissue invasiveness in experimental conditions after exposure to its 
corresponding ligand, CpG DNA
96
.  
The role of TLR2, -3 and -4 in MSC is rather different: the first one, upon 
stimulation, maintains BM-MSC in a proliferative and self-renewing state without 
affecting neither their immunosuppressive properties
97
 nor their potential for 
multipotent differentation
97
. On the contrary, TLR3 and -4 do not appear to 
predominantly affect differentiation
21
, but rather to influence BM-MSC stress responses 
and migration
22
. Most of all, they are pivotal elements in the regulation of the powerful 
immunomodulative effects exerted by BM-MSC. 
Initial findings seemed to indicate that the engagement of TLR3 and TLR4 on 
MSC could dynamically revert the baseline immunomodulatory functions exerted by 
these cells, enabling a normal response of lymphocytes to either specific and unspecific 
stimuli even in the presence of MSC in coculture
21
. The mechanism underlying this 
function consists in a TLR3/4 dependent down-regulation of MSC surface Jagged1. 
Besides acting on immunomodulatory functions, the triggering of TLR3 and TLR4 also 
convert BM-MSC into powerfully chemotactic cells by increasing their production of 
IL-1, IL-6, IL-8/CXCL8, CCL5, IP10/CXCL10 and monocyte chemotactic protein 
(MCP)-1 via activation of NF-kB signaling
21-23,98
. Similar results have been obtained in 
adipose-tissue derived MSC, where TLR agonists increased mRNA production of MCP-
1 and -2, granulocyte chemotactic protein-2 (GCP-2), IL-1, macrophage inflammatory 
protein-3 (MIP-3), TNF- and IL-1295. Both MyD88-dependent and MyD88-
22 
 
independent pathways have shown to be involved in transmitting the signals 
downstream of TLR4 activation on MSC
99
. 
As such, TLR3 and TLR4 stimulation on MSC was initially thought to induce a 
dynamic, reversible block of their immunosuppressive features and to switch these cells 
towards the production of several chemokines and proinflammatory cytokines, thus 
helping the proper development of inflammation in the presence of exogenous threats, 
such as bacteria (sensed by TLR4) and viruses (TLR3)
98
. 
 
Later studies proved the situation to be rather more complicated. First of all, the 
functional, dynamic block of MSC immunomodulative properties by TLR3 and TLR4 
stimulation reported by Liotta and colleagues required IDO1 activity to be bypassed
100
. 
Then, effects of TLR triggering on MSC seemed to depend on tissue source of 
expanded cells, as TLR2, TLR3 and TLR4 ligation did not appear to affect the ability of 
human adipose tissue-derived MSC to suppress lymphocyte activation
101
. The condition 
of the microenvironment could also influence the response to TLR triggering: e.g. 
culturing MSC in an inflammatory milieau resulted in the upregulation of TLR2, TLR3 
and TLR4, and in an increased proinflammatory shift in their cytokine profile after 
exposure to both poly(I:C) and LPS
102
. Finally, conflicting results were recently 
described in lymphocyte:BM-MSC cocultures after short-term (1 hour), low-level 
(poly(I:C) 1 g/ml; LPS 10 ng/ml) stimulation of BM-MSC with either TLR3- or 
TLR4-ligands
103
. In this latter study, TLR4-primed MSC exhibited a pro-inflammatory 
profile, with increased levels of cytokines such as IL-6, IL-8/CXCL-8 or TGF-, while 
TLR3-primed MSC exerted increased immunosuppressive activities, by producing 
mainly IL-10, IDO and PGE2
103
. Interestingly, multipotent differentiation and 
extracellular matrix deposition in this model were also differently affected after TLR3 
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or TLR4 activation
103
. In analogy with the M1/M2 monocyte/macrophage 
polarization
104
, a similar functional priming has therefore been hypothesized for MSC 
by these authors
103
: accordingly, a MSC1 “pro-inflammatory” would oppose to a MSC2 
“immunosuppressive” phenotype103, and the specific activation of different TLRs on 
MSC would push the cells towards one phenotype or the other. 
However, there is evidence that TLR3 or TLR4 activation on MSC results in 
very different outcomes depending on the specific experimental conditions, on the 
concentration of the respective ligands, on the duration of the stimuli and on the 
coculture ratios with interacting cells. As shown by others
95,101,105
, the pattern of 
expression of TLRs and the outcome of their signaling may also depend on the tissue 
source used to expand MSC, even though BM-MSC still serve as the fundamental 
model for all other types of MSC. 
Therefore, the real capacity of TLR4 to polarize MSC specifically towards 
MSC1 phenotype, and, on the other hand, the ability of TLR3 to promote an exclusive 
MSC2 polarization, as proposed by Waterman and colleagues
103
, is still uncertain. 
 
Do Mesenchymal Stromal Cells affect Neutrophil biology ? 
As it is well known, besides acting as first line phagocytes, neutrophils (PMN) 
are far more complex cells, capable of intense biological activity
55
. Upon challenge by 
various
 
stimuli, they release lytic enzymes
 
with powerful antimicrobial potential, and 
generate reactive oxygen intermediates (ROI), which are essential for pathogen
 
killing
55
. 
Neutrophils can also be induced to produce de novo a variety of mediators involved in 
their functions
69 
and, in turn, they cross-talk with immune
106-108
 and non immune 
effector cells
109
. Nevertheless, it was unclear until recent studies whether an interaction 
existed between these cells and BM-MSC. 
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In 2008, a study by Raffaghello and colleagues clarified that while neutrophils 
are normally short-living cells, they display a significantly lower tendency to undergo 
apoptosis when cocultured with untreated BM-MSC, for up to 40 hours and particularly 
if coincubated at high PMN:BM-MSC ratio (50:1)
110
. Concomitantly, the capacity of 
neutrophils of producing hydrogen peroxide upon fMLF-stimulation decreases under 
coculture conditions, while their chemotactic ability or their CD11b or CD62L 
expression remain unaffected
110
. All these effects are not only reproduced by culturing 
neutrophils in BM-MSC-conditioned supernatants, but also fully dependent on IL-6
110
, 
which is constitutively produced at high concentrations by BM-MSC
75,110
. 
More recently, supernatants from parotid-derived MSC stimulated via TLR4 by 
LPS also proved to significantly improve neutrophil survival and chemotaxis
111
. 
However, even if MSC supernatants were shown in this study to contain G-CSF, IL-6, 
IL-8/CXCL8 and MIF, no functional analysis was performed to identify the factors 
specifically responsible for their effects
111
. 
 
It is currently unknown whether other factors could influence the relationship 
between neutrophils and BM-MSC. At the same time, the mechanisms by which these 
cells interact are still unclear, even if soluble factors are thought to be responsible for 
the observed effects. 
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AIM OF THE STUDY 
In the present study, we examined whether MSC isolated and expanded in vitro 
from bone marrow, thymus, spleen and adipose tissue can modify neutrophil survival, 
phenotype and function after activation by either poly(I:C), a specific ligand for TLR3, 
or LPS, a ligand for TLR4. 
We demonstrate here that both TLR3 and TLR4 activation result in significantly 
increased and prolonged survival by neutrophils, much more potent than what observed 
in resting conditions. At the same time, we demonstrate this effect to be linked to 
neutrophil activation, as showed by increased CD11b expression and enhanced potential 
for respiratory burst activity after coculture. We show that TLR3-activated BM-MSC 
are more powerful than TLR4-stimulated BM-MSC in exerting such effects, and that 
these properties are shared by all the types of MSC that we used, regardless of their 
source (bone marrow, thymus, spleen and adipose tissue).  
Finally, we test the mechanisms for these effects, by virtually reproducing all 
results with supernatants taken from TLR3- and TLR4-stimulated BM-MSC, by testing 
their content of cytokines well-known for their action on neutrophil survival and 
functions (IL-6, IL-8, IFN-, IFN-, IFN-, G-CSF, GM-CSF, TNF-), and by 
performing blocking experiments by means of specific neutralizing monoclonal 
antibodies. We show that a concerted action of endogenously produced IL-6, IFN- and 
GM-CSF determines most of the modulatory effects exerted on neutrophils by TLR3-
activated BM-MSC, while GM-CSF is solely responsible for most of those exerted by 
TLR4-activated BM-MSC.  
Taken together, these observations highlight a novel mechanism by which tissue 
resident MSC may sustain and amplify the functions of neutrophils upon TLR 
activation in physiological and pathological conditions. 
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MATERIALS AND METHODS 
 
Neutrophil purification 
Following isolation under endotoxin-free conditions from buffy coats of healthy 
blood donors, as described elsewhere
53,107,112
, neutrophils were enriched by 
immunomagnetic depletion of committed blood cells, which was obtained using a 
customized EasySep® kit (Stem Cell Technologies/Voden, Casorezzo, Italy), consisting 
of a mixture of  monoclonal antibodies against human CD3, CD19, CD36, CD49d, 
CD56 and glicophorin-A
53,107,112
. PMN were then resuspended in endotoxin-free RPMI 
supplemented by 10% FBS (EU LPS level) and 1% penicillin/streptomycin (all 
purchased by GIBCO/Invitrogen, S.Giuliano Milanese, Italy), and used immediately. 
Purity was tested by monoclonal antibodies against human CD16, CCR3, CD3 (all by 
BD Biosciences, Buccinasco, Italy), CD66b (Beckman-Coulter, Milano, Italy), and flow 
cytometry (BD FACScalibur™) (Figures 5-6). Mean final purity was 99.1% (range: 
98.5 – 99.8%). 
 
Mesenchymal Stromal Cells purification and culture 
Mesenchymal stromal cells (MSC) were isolated from bone marrow (BM), 
thymus, spleen and subcutaneous lipoaspirates obtained from healthy donors after 
informed consent and expanded in vitro. Briefly, following density gradient 
centrifugation, BM mononuclear cells were plated without sorting at the initial (P0) 
density of 1.2 x 10
6
 cells/cm
2
 in DMEM supplemented with 18% FBS and 1% 
penicillin/streptomycin (complete medium; all by GIBCO/Invitrogen, S. Giuliano 
Milanese, Italy). To obtain thymic, splenic and adipose-tissue MSC, small fragments of 
each tissue and 50 ml of lipoaspirate were collected from healthy donors undergoing the  
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FIGURE 5. Cytofluorimetric physical parameters of Neutrophils and BM-MSC.  
 
Neutrophils are clearly distinguishable from BM-MSC in a morphological cytofluorimetric gate 
(SSC-H /  FSC-H) because of their very different physical parameters. 
 
FIGURE 6. Effect of immunomagnetic purification of Neutrophils. 
 
Standardly isolated Neutrophils have been stained and analyzed by FACS to test their purification 
level and potential contaminant cells, e.g. CD16
low
/CCR3
+
 cells (eosinophils) or CD3
+
 cells (T-
lymphocytes; both indicated by the red ovals). Analysis is performed on the morphological gate 
indicated in the first row and based on PMN physical parameters. The second column shows the 
disappearance of most of the contaminant cells after the immunomagnetic depletion with mAbs 
targeted against specific markers of blood cells other than neutrophils.  
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specific surgical procedure for unrelated reasons. Samples were digested with a 
collagenase solution (0.075% in HBSS) at 37 °C in a thermic steady state shaking 
incubator (120 rpm) for 30 minutes
78,113
. The cell suspensions derived from the 
disaggregation of  thymic and splenic samples were then collected, the collagenase was 
neutralized by dilution in complete medium at a 1:3 ratio, the cellular pellet was 
collected after centrifugation, and contaminating erythrocytes were lysed by means of a 
160 mM NH4Cl solution (Sigma-Aldrich, Milano, Italy) (10 minutes, room 
temperature). Finally, cells were plated in complete medium at the initial density of 10 x 
10
6
 cells/cm
2
 for thymic cells and 5 x 10
6
 cells/cm
2
 for splenocytes
113
. The adipose 
tissue-derived cell suspension containing the vascular-stromal fraction was collected 
after collagenase neutralization and centrifugation at 200g for 10 minutes at room 
temperature. Cells were then filtered through a 100 µm cell strainer and plated in 
complete medium at the initial density of 1 x 10
6
 cells/cm
2
, as described elsewhere
78,113
.  
Following a brief expansion in complete medium, cells displayed a homogeneous 
mesenchymal immunophenotype starting from passages 2-3 (P2-3) (Figures 5 and 7) 
and proved capable of in vitro multilineage differentiation into adipocytes, osteoblasts 
and chondrocytes after exposure to specific differentiating media, as described 
elsewhere
78,113
. Medium was entirely changed with fresh RPMI supplemented with 10% 
FBS and 1% penicillin/streptomycin at the start of each coculture experiment. 
Immunophenotypic analysis was performed after 2 or 3 passages (P2-3) using 
monoclonal antibodies against human CD106, CD105, CD73, CD80, CD86, CD45, 
CD34, CD31, CD11c, CD146 (all by BD Biosciences, Buccinasco, Italy) and flow 
cytometry
78,113 
(Figure 8). For each experiment 10
4
 events were counted.  
Expanded cells displayed the ability to differentiate in vitro into adipocytes, 
osteoblasts and chondrocytes after exposure to specific induction media, 
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FIGURE 7. BM-MSC in vitro culture. 
 
BM-MSC growth in vitro. A-C: during expansion, BM-MSC tend to progressively grow from single 
cells (A) to clusters of spindle-shaped cells (B), to confluent monolayers (C). D: Clusters of cells 
grow to progressive confluence. Magnification: A: 400x (scale bar = 40 m. B-D: 100x (scale bar = 
200 m).  
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FIGURE 8. Immunophenotype of in vitro expanded BM-MSC (P4). 
 
The expression of each marker is highlighted in green as frequency distribution of fluorescence 
intensity, and compared to that of isotype controls (red lines). 
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FIGURE 9. Multipotent differentiation of BM-MSC in vitro. 
 
Columns  indicate  differentiated  lineages  obtained after exposing BM-MSC to the respective induction  media  for 21 days,  and  
revealed by specific histochemical stainings. First row indicates BM-MSC kept in standard culture medium in the same conditions, 
and used as controls. Magnification: first two rows: 100x (scale bar = 100 m); third row (detail): 200x (scale bar = 100 m). 
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as described elsewhere
78,113
 (Figure 9). 
 
PMN:MSC cocultures 
Neutrophils (99.1% ± 0.5% purity) and MSC were cocultured for up to 44 hours 
(Figure 10) in RPMI 1640 medium supplemented with 10% FBS and 1% 
penicillin/streptomycin (all by GIBCO/Invitrogen, S.Giuliano Milanese, Italy), at 
PMN:MSC ratios ranging from 1,000:1 to 10:1, in the presence or absence of 100 g/ml 
poly(I:C) (InvivoGen, San Diego, CA) or 100 ng/ml LPS (Ultra-Pure E.coli LPS, Alexis 
Biochemicals, San Diego, CA), according to preliminary experiments performed to 
determine the optimal working concentrations (Figure 11). In all cases, MSC were 
plated 24 hours before the start of cocultures. In selected experiments, neutrophils were 
cultured on top of 0.4 m-pore size Transwell® inserts (Corning Costar, Cambridge, 
MA) to prevent cell contact between neutrophils and MSC. At the end of the incubation, 
neutrophils were harvested by careful pipetting, ultracentrifuged at 600 x g for 5 
minutes, and finally resuspended in PBS for subsequent assays. Full integrity of MSC 
layers was checked in all cases. 
MSC-conditioned media were obtained by incubating the same MSC batches 
used for the cocultures with neutrophils in the presence or absence of poly(I:C) or LPS 
for 24 hours, and then by collecting and processing their cell-free supernatants. 
Cytokine blocking experiments were conducted by culturing neutrophils in MSC-
conditioned media previously preincubated for 30 minutes at 37 °C in the presence of 
specific neutralizing monoclonal antibodies (mAbs) towards G-CSF, GM-CSF (both 
from R&D Systems, Minneapolis, MN), IL-8/CXCL8 (PeproTech, Rocky Hill, NJ), 
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FIGURE 10. Neutrophils : BM-MSC coculture. 
 
BM-MSC have been plated on the bottom of 24-48-96-well plates 24 h before the start of coculture 
in order to obtain a confluent monolayer. Following fresh isolation, neutrophils have been plated on 
top of the monolayer or, alternatively, in a Transwell insert, when needed. Colture medium has 
been changed at the start of the coculture. Magnification: 100x (first and second rows); 400x (third 
row). Scale bar represents 100 m. 
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FIGURE 11. Modulation of neutrophil apoptosis by BM-MSC after coculture with 
increasing concentrations of poly(I:C) or LPS. 
 
 
Neutrophils (PMN) were cultured for 20 hours with or without BM-MSC at 10:1 ratio, in the 
absence or presence of the indicated concentrations of poly(I:C) or LPS. Apoptosis was measured 
and neutrophils that were double negative by the Annexin-V/PI method (see Materials & Methods) 
were considered as viable: their percentage is reported as percentage of total. One representative 
experiment for each TLR-agonist is presented. 
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IFN- (clone B133.3, kindly provided by Dr Giorgio Trinchieri, National Cancer 
Institute, Frederick, MD) and TNF- (clone B154.2, kindly provided by Dr Giorgio 
Trinchieri, National Cancer Institute, Frederick, MD). Alternatively, neutrophils were 
preincubated for 30 minutes with anti-IL-6R (Bender MedSystems, Wien, Austria), 
anti-type-I IFN-R (MMHAR-2; PBL InterferonSource, Piscataway, NJ), or, in the case 
of the subsequent culture in LPS-conditioned supernatant, also anti-TLR4 mAbs (kindly 
provided by Dr Greg Elson, Novimmune, Geneve, Switzerland), prior to their further 
culture. 
 
Cytofluorimetric analysis  
After isolation from MSC, neutrophils were identified on the basis of their 
typical morphological parameters (FSC/SSC) (Figure 5). We tested the level of 
neutrophil apoptosis by the Annexin-V-FLUOS Apoptosis Detection kit by Roche 
Diagnostics (Mannheim, Germany) and flow cytometry analysis (FACS, BD 
FACScalibur™). Following collection from the well plates, neutrophils were 
ultracentrifuged at 3000 rpm and the pellet resuspended in 100 l of isotonic binding 
buffer; neutrophils were then incubated at the final concentration of 4x10
3
 PMN/l in a 
working solution of Annexin-V/propidium-iodide (1:100 stock dilution, in isotonic 
binding buffer), 15 minutes in the dark, additioned with 250 l PBS and immediately 
analyzed by flow cytometry (BD FACScalibur™). The expression of CD16, CD11b and 
CD64 on neutrophils was also evaluated by FACS (all antibodies by BD Biosciences, 
Buccinasco, Italy; incubation for 30 minutes at 4 °C; 10
4
 events counted for each 
condition). Prior to the staining with the specific fluorochrome-conjugated antibody, 
neutrophils were resuspended and incubated with human serum (10% solution) for 30 
minutes at 4 °C. 
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Enzyme-Linked Immunosorbent Assay (ELISA) 
Cytokine concentrations in BM-MSC-free supernatants were measured by 
commercially available ELISA kits for: human IL-6 (detection limit 0.6 pg/ml; 
Immunotools, Friesoythe, Germany), IL-8/CXCL8 (detection limit 1 pg/ml; 
Immunotools, Friesoythe, Germany), IFN- (detection limit 12.5 U/ml; PBL 
InterferonSource, Piscataway, NJ), IFN- (detection limit 2.5 U/ml; 
Biosource/Invitrogen, S.Giuliano Milanese, Italy), IFN- (detection limit 2.0 pg/ml; 
clone B133.3; Immunotools, Friesoythe, Germany), G-CSF (detection limit 0.4 pg/ml; 
R&D Systems, Minneapolis, MN), GM-CSF (detection limit 2 pg/ml; BioLegend, San 
Diego, CA), TNF- (detection limit 0.09 pg/ml; human high-sensitivity kit by 
Invitrogen, Cat.# KHC3014, S.Giuliano Milanese, Italy), according to the respective 
manufacturer’s instructions. 
 
Respiratory burst 
Superoxide anion (O2
-
) release was estimated by the cytochrome C reduction 
assay
114
. Briefly, following neutrophil/BM-MSC coculture in a 96-well plate, medium 
was gently removed and replaced 0.2 ml of HBSS/well (pH 7.4), containing 80 µM 
cytochrome C (Sigma-Aldrich, Milano, Italy) and 2 mM NaN3, in the presence or 
absence of 100 nM N-formylmethionyl-leucyl-phenylalanine (fMLF) (Sigma-Aldrich, 
Milano, Italy). The plate was then analyzed by an automated plate-reader (ELX808, 
Bio-Tek Instruments, Winooski, VT), prewarmed at 37 °C, and absorbance at 550 nm 
and 468 nm was recorded every 5 minutes. O2
-
 production was calculated in 
nanomoles/1.5x10
5
 PMN/min using 24.5 mM
-1
cm
-1
 as extinction coefficient. Each 
condition was performed in groups of triplicate samples. 
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Western blot analysis and native gels 
After stimulation with LPS or poly(I:C), 1 x 10
6
 BM-MSC for each condition 
were diluted in ice-cold D-PBS and centrifuged twice at 300g for 5 minutes at 4 °C. The 
resulting cell pellets were lysed with radioimmune precipitation assay (RIPA) buffer (25 
mM Tris, pH 7.5, 150 nM NaCl, 1% Triton X-100, 1% sodium deoxycholate and 0.1% 
SDS) containing 1 mM DTT and antiprotease and antiphosphatase mixtures. Following 
a 20-minute incubation on ice, samples were centrifuged at 13000g (15 minutes, 4 °C), 
and the resulting supernatants were divided in aliquots and immediately stored at -80 
°C. Small aliquots of the various samples were routinely processed for protein content 
determination by using a protein assay kit (Bio-Rad, Segrate, Italy). For Western blot 
analysis, protein extracts were subjected to electrophoretic separation on SDS-PAGE 
and subsequent transfer to nitrocellulose by electroblotting using standard procedures. 
Nitrocellulose membranes were first blocked for 1 hour at room temperature in Odyssey 
buffer and then incubated overnight at 4 °C, in the presence of specific primary 
antibodies in the same buffer. Antibodies against phospho-tyrosine STAT1, phospho-
IRF3, phospho-p38 and phospho-ERK were purchased from Cell Signaling 
Technologies (Danvers, MA). Antibodies against total-STAT1, IRF3 and IkBa were 
purchased from SantaCruz (Santa Cruz, CA), while antibodies against -actin were 
purchased from Sigma-Aldrich. Detection was carried out with Alexa Fluor 680 goat 
anti-rabbit Ab (Molecular Probes/Invitrogen, S.Giuliano Milanese, Italy) and IRDye 
TM800-conjugated goat anti-mouse IgG (Rockland, Gilbertsville, PA) secondary Ab. 
Blotted proteins were detected using the Odyssey infrared imaging system (LI-COR 
Biosciences, Cambridge, UK). Native PAGE was performed as previously described
112
. 
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Statistical analysis 
One-way Analysis of Variance (ANOVA) and Holm-Sidak test for multiple 
comparisons were used to statistically evaluate the difference of sample means among 
multiple groups. A P value <0.05 was considered as significant. Data are represented 
using mean ± standard deviations (SD) in all cases. Calculations have been performed 
using STATA IC v.10.0 (StataCorp, College Station, TX). 
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RESULTS 
 
BM-MSC exert a powerful pro-survival effect on neutrophils upon activation by 
TLR3- or TLR4-agonists  
Highly purified populations of peripheral neutrophils were plated with in vitro 
expanded BM-MSC at coculture ratios ranging from 1,000:1 to 10:1, either in direct 
contact or in Transwell® conditions. Viability and expression levels of surface markers 
in neutrophils were investigated after 20 hours of incubation, unless differently 
specified. As shown in Figures 12-13, neutrophil survival was enhanced by untreated 
BM-MSC only at 10:1 PMN:BM-MSC ratio, going from 18.5 ± 6.6% viability in the 
absence of BM-MSC, to 44.4 ± 9.5% (P<0.001) (Figure 12). Under the latter 
conditions, the protective effect of BM-MSC was already significant after 6 hours and 
lasted up to 44 hours of culture, although not significantly anymore (Figure 14). 
Cocultures performed by using Transwell® inserts yielded similar results, with 
neutrophil survival ranging from 22.9 ± 12.3% (in the absence of BM-MSC, data not 
shown) to 39.6 ± 10.9% (P<0.01) (Figures 12-13). These results substantially confirm 
and extend previous observations aimed at defining whether resting BM-MSC could 
influence neutrophil viability
110
. 
To subsequently investigate whether activated BM-MSC could exert enhanced 
modulatory effects on neutrophil survival, we performed the cocultures in the presence 
of poly(I:C), the specific ligand of TLR3, which is expressed and functional in BM-
MSC
21-23
 but not in neutrophils
3,112
 (Figures 12-13). Under these conditions, the 
survival rate of neutrophils was strongly increased and already significant at the 100:1 
PMN:BM-MSC ratio (49.5 ± 13.2%, P<0.001), but was maximum at the 10:1 ratio 
(73.6 ± 6.8%, P<0.001) (Figures 12-13). 
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FIGURE 12. BM-MSC exert a powerful prosurvival effect on neutrophils under 
coculture conditions in the presence of either poly(I:C) or LPS. 
 
 
A. Bars indicate the survival levels of 
neutrophils (PMN) after coculture for 20 
hours with or without BM-MSC either in 
direct contact or in Transwell®, at ratios 
ranging from 1,000:1 to 10:1, in the absence 
or presence of 100 g/ml poly(I:C) or 100 
ng/ml LPS. Neutrophils that were double 
negative by the Annexin-V/PI method (see 
Materials & Methods) were considered as 
viable: their percentage is reported as 
percentage of the total. Results are expressed 
as mean ± SD (n≥12 in all cases).  
P values <0.05 were considered as statistically 
significant (*: P<0.05; **: P<0.01; ***: 
P<0.001). 
 
B. Bars report the net prosurvival effect 
exerted by BM-MSC on neutrophils under 
the conditions reported in panel A. Data were 
calculated by considering the difference 
between the survival rate at 20 hours of 
neutrophils under the various coculture 
conditions over the survival rate of 
neutrophils cultured alone without TLR-
agonists. The light grey fraction of the bars 
representing the cocultures treated with LPS 
better visualizes the net effect exerted by 
LPS-stimulated BM-MSC over the effect 
exerted by LPS by itself on neutrophils. 
Results are expressed as mean ± SD (n≥12 in 
all cases). 
 
C. Bars report the percentage of increase of 
neutrophil survival in PMN:BM-MSC 
cocultures as compared to PMN-only 
cultures carried out with or without the 
corresponding TLR-agonists. Results are 
expressed as mean ± SD (n≥12 in all cases). 
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FIGURE 13. Representative Annexin-V/propidium-iodide (PI) plots displaying the 
neutrophil prosurvival effect exerted by poly(I:C)- or LPS-activated BM-MSC 
under coculture conditions. 
 
The figure shows a representative experiment, performed as detailed in the legend of Figure 12. 
The percentage of double negative PMN, considered as viable, is shown in each condition. 
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FIGURE 14. Time course analysis of the viability of neutrophils during their 
coculture with resting and activated BM-MSC. 
 
 
Neutrophils (PMN) were cocultured with or 
without BM-MSC as detailed in the legend of 
Figure 12 and harvested at different time 
points (0, +2, +6, +20 and +44 hours) to 
measure their viability. Double negative 
neutrophils with the Annexin-V/PI method 
were considered as viable and their 
percentage is reported as percentage of the 
total. Results are expressed as mean ± SD 
(n=3).  
Panel A displays the survival in cultures 
without TLR-agonists, while Panel B and 
Panel C display cultures with the addition of 
poly(I:C) and LPS, respectively.  
Results was statistically compared to PMN 
cultures carried out without TLR-agonists, 
and P values <0.05 was considered as 
statistically significant (*: P<0.05; **: 
P<0.01; ***: P<0.001). 
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Notably, at 10:1 ratio the degree of neutrophil survival was maintained at very high 
levels up to 44 hours (Figure 14), even under Transwell® conditions (60.2 ± 12.4%, 
P<0.001) (Figures 12-14), thus suggesting the involvement of endogenous soluble 
factors. 
For comparison, PMN:BM-MSC cocultures were also performed in the presence 
of LPS, well considering, however, that both BM-MSC
21-23,111
 and neutrophils
3,112
 
express functional TLR4, the specific LPS receptor
59
, and do respond to its ligands. In 
fact, LPS itself, in the absence of BM-MSC, significantly delayed neutrophil apoptosis 
(Figures 12-14), in line with the literature
3,55,65
. Nonetheless, we further observed that 
neutrophil survival was additionally increased in LPS-treated PMN:BM-MSC 
cocultures, being apparently more pronounced than under poly(I:C)-treatment (75.0 ± 
4.1%, P<0.001 at the 100:1 ratio; 82.4 ± 4.4%, P<0.001, at the 10:1 ratio) (Figures 12-
13). However, LPS activates neutrophils also directly and this effect has to be 
distinguished from that dependent only on TLR4-triggering on BM-MSC. Thus, 
poly(I:C)-stimulated BM-MSC eventually resulted more efficient than LPS-stimulated 
BM-MSC in protecting neutrophil viability, when considering the net protective effects 
over the basal viability of neutrophils cultured without TLR-agonists (Figure 12B), as 
well as the percentage of increased neutrophil survival observed in PMN:BM-MSC 
cocultures as compared to PMN-only cultures, with or without the corresponding TLR-
agonists (Figure 12C). 
Accordingly, the net antiapoptotic effect of LPS was less sustained than 
poly(I:C) also in time-course studies, as it remarkably declined between 20 and 44 
hours (Figure 14C). On the other hand, Transwell® experiments proved that soluble 
factors were greatly responsible for the protection of neutrophil survival also in the case 
of LPS-treated PMN:BM-MSC cocultures (Figure 12 and Figure 13).  
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Taken together, these data show that BM-MSC activated with agonists for TLR3 
and - less efficaciously - TLR4, delay neutrophil apoptosis much more significantly 
than resting BM-MSC. 
 
Immunophenotypic changes by neutrophils after coculture with resting or TLR-
activated BM-MSC 
As previously described, CD16 (FcR-III) can be reliably used as a surrogate 
marker of neutrophil viability
115
; accordingly, we observed that the percentage of 
neutrophils retaining high levels of CD16 expression (CD16
high
 PMN) matched the 
percentage of viable neutrophils under all coculture conditions (Figures 15-16). On the 
other hand, CD11b is typically modified by neutrophil activation
107,114
, and was used in 
our study as a marker of the activation status of neutrophils.  
As expected, neither the percentage of CD16
high
 neutrophils (Figures 15-16), nor 
the expression of CD11b (Figures 17-18) changed when neutrophils were cultured 
alone in the presence of poly(I:C). By contrast, the percentage of CD16
high
 neutrophils 
was significantly higher when neutrophils were cultured in the presence (43.37% ± 
13.92%) rather than in the absence (17.74% ± 9.38%; P<0.001) of BM-MSC, at the 
10:1 coculture ratio (Figures 15-16). A significant increase of CD16
high
 neutrophils was 
observed by adding either poly(I:C) (68.54% ± 10.09%; P<0.001) or LPS (74.56% ± 
9.43%; P<0.001) to PMN:BM-MSC cocultures, similarly to what observed regarding 
the prosurvival effect. These data were comparable to the results obtained under 
Transwell® conditions (Figures 15-16).  
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FIGURE 15. Poly(I:C) or LPS-activated BM-MSC maintain higher levels of CD16 
expression by neutrophils in coculture. 
 
 
Neutrophils (PMN) were cultured as detailed 
in the legend of Figure 12 and then analyzed 
for CD16 expression by FACS analysis (see 
Materials&Methods). 
 
A. Bars refer to the percentage of neutrophils 
maintaining a high level of CD16 expression 
(CD16
high
 PMN, see Materials & Methods) 
under the conditions detailed in Figure 12. 
Results are expressed as mean ± SD (n≥12 in 
all cases).  
P values <0.05 were considered as statistically 
significant (*: P<0.05; **: P<0.01; ***: 
P<0.001). 
 
B. Bars report the net protective effect on 
neutrophil CD16 expression exerted by BM-
MSC, under the conditions detailed in Figure 
12, as calculated by considering the difference 
between the level of CD16 expression at 20 
hours in the various coculture conditions over 
the level expressed by neutrophils cultured 
alone without TLR-agonists.  
As in Figure 12B, the light grey fraction of the 
bars representing the cocultures treated with 
LPS better visualizes the net effect exerted by 
LPS-stimulated BM-MSC over the effect 
exerted by LPS by itself on neutrophils. 
Results are expressed as mean ± SD (n≥12 in 
all cases). 
 
C. Bars report the percentage of increase of 
CD16
high
 PMN in PMN:BM-MSC cocultures 
as compared to PMN-only cultures realized 
with or without the corresponding TLR-
agonists. Results are expressed as mean ± SD 
(n≥12 in all cases). 
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FIGURE 16. Representative plots displaying the levels of CD16 expression in 
neutrophils after coculture with poly(I:C)- or LPS-activated BM-MSC. 
 
The figure shows a representative experiment, performed as detailed in the legend of Figure 12. 
The percentage of PMN characterized by high level of CD16 expression (CD16
high
 PMN) is shown 
in each condition. 
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FIGURE 17. BM-MSC strongly upregulate neutrophil CD11b expression under 
coculture conditions in the presence of either poly(I:C) or LPS. 
 
 
Neutrophils (PMN) were cultured as detailed 
in the legend of Figure 12 and then analyzed 
for CD11b expression by FACS analysis (see 
Materials & Methods). 
 
A. Bars indicate the geometric mean of 
fluorescence intensity (MFI) ± standard 
deviation (SD) of CD11b in neutrophils 
(PMN) under the conditions detailed in Figure 
12 (n≥12 in all cases).  
P values <0.05 were considered as statistically 
significant (*: P<0.05; **: P<0.01; ***: 
P<0.001). 
 
B. Bars report the geometric mean ± SD of the 
percentage of increase on CD11b expression 
exerted by BM-MSC under the conditions 
detailed in Figure 12 (n≥12 in all cases). The 
increase was calculated by considering the 
difference at 20 hours between the levels of 
CD11b expression observed in neutrophils 
cultured in the various conditions and 
neutrophils cultured alone without TLR 
agonists, and it was expressed as percentage of 
the level of CD11b expression observed in 
neutrophils cultured alone without TLR 
agonists. 
As in Figure 12B, the light grey fraction of the 
bars representing the coculture treated with 
LPS better visualizes the net upregulatory 
effect exerted on CD11b expression by LPS-
stimulated BM-MSC over the effect exerted 
by LPS by itself on neutrophils.  
 
C. Bars report the percentage of increase of 
CD11b expression levels in PMN:BM-MSC 
cocultures as compared to PMN-only cultures 
carried out with or without the corresponding 
TLR-agonists. Results are expressed as mean 
± SD (n≥12 in all cases). 
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FIGURE 18. Representative plots displaying the levels of CD11b expression in 
neutrophils after coculture with poly(I:C)- or LPS-activated BM-MSC. 
 
The figure shows a representative experiment, performed as detailed in the legend of Figure 12. 
The geometric mean of CD11b fluorescence intensity (MFI) is shown in each condition. 
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On the other hand, the expression level of CD11b was unchanged by coculturing 
neutrophils with untreated BM-MSC, regardless of coculture ratios and the use of 
Transwell® inserts (Figures 17-18). By contrast, CD11b was significantly upregulated 
if poly(I:C) was added to PMN:BM-MSC cocultures (Figures 17-18). Similarly, the 
direct upregulatory effects of LPS on the percentage of CD16
high
 neutrophils and CD11b 
expression levels in neutrophils cultured without BM-MSC were also greatly amplified 
by BM-MSC (Figures 15-16), peaking already at the 100:1 PMN:BM-MSC ratio. 
These effects appeared effectively mediated by LPS-activated BM-MSC when 
considering the results according to the same procedures detailed for panels B and C of 
Figure 12, aimed to detect the net effects of the cocultures as compared to the effect of 
LPS itself on neutrophils cultured alone (Figures 15B-C and 17B-C). Interestingly, 
similar results concerning the percentage of CD16
high
 neutrophils and CD11b expression 
level were obtained under Transwell® conditions in LPS-activated PMN:BM-MSC 
cocultures (Figure 15 and Figure 17). However, the higher variability observed in 
cocultures using Transwell® inserts partially limited the statistical significance of the 
immunophenotypic changes observed. 
Taken together, these data demonstrate that TLR3- and TLR4-stimulated BM-
MSC better preserve neutrophils expressing high-intensity CD16 and CD11b than 
resting BM-MSC. 
 
Coculture with BM-MSC “primes” neutrophils for increased respiratory burst ability  
The coculture with BM-MSC modified also the capacity of neutrophils of 
producing superoxide anion (O2
-
) in response to fMLF (Figure 19). Accordingly, while 
neutrophils cultured for 20 hours in the absence of BM-MSC and then stimulated with 
fMLF for up to 40 minutes resulted unable to release O2
-
 (Figure 19), they properly 
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responded to fMLF challenge if preincubated for 20 hours with LPS, but not with 
poly(I:C) (Figure 19). Remarkably, neutrophils previously cocultured with resting BM-
MSC also displayed a significant ability to release O2
-
 following exposure to fMLF, 
which was further enhanced if PMN:BM-MSC cocultures were carried out in the 
presence of either poy(I:C) or (at higher levels) LPS (Figure 19). 
 
FIGURE 19. Coculture with BM-MSC primes neutrophils for increased 
respiratory burst. 
 
Neutrophils (PMN) were cocultured for 20 hours with or without BM-MSC at a 10:1 ratio, in the 
absence or presence of 100 g/ml poly(I:C) or 100 ng/ml LPS. Superoxide anion (O2
-
) production in 
response to 100 nM fMLF was then estimated by the cytochrome C reduction assay of triplicate 
samples. Absorbance at 550/468 nm was recorded every 5 minutes for the times shown. O2
-
 
production was calculated in nanomoles/1.5x10
5
 PMN/minute using 24.5 mM as extinction 
coefficient. The figure shows a representative experiment out of three performed with similar 
results. 
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 BM-MSC-conditioned supernatants virtually reproduce all the effects observed in 
PMN:BM-MSC cocultures  
By culturing neutrophils in supernatants from either resting, poly(I:C)-, or LPS-
stimulated BM-MSC, the same effects detected under Transwell® cocultures were 
substantially observed in terms of both neutrophil survival and phenotypic changes 
(Figure 20). However, conditioned media from poly(I:C)-treated BM-MSC were 
slightly more efficient than supernatants from LPS-stimulated BM-MSC in enhancing 
the percentage of viable, CD16
high
 and CD11b
+
 neutrophils (Figure 20). It is worth to 
note here that neutrophils were pretreated with a specific TLR4 blocking antibody
116 
prior to their incubation with the supernatant from LPS-stimulated BM-MSC. The 
efficacy of TLR4 blocking in fully neutralizing the effects mediated by LPS is shown in 
Figure 21.  
Overall, these data confirm that soluble factors contribute to mediate the 
modulatory effects exerted on neutrophils by resting or TLR-activated BM-MSC.  
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FIGURE 20. Effects of BM-MSC-conditioned supernatants on neutrophil viability 
and expression of CD16 or CD11b. 
 
 
 
 
BM-MSC were cultured for 24 hours with or 
without 100 g/ml poly(I:C) or 100 ng/ml 
LPS, before collecting their supernatants. 
Freshly-isolated neutrophils were then 
incubated with the various BM-MSC-
conditioned supernatants and analyzed after 
20 hours for viability (A), CD16 (B) and 
CD11b (C) expression.  
Bars in panel B represent the percentage of 
CD16
high
 PMN in the various conditions; bars 
in panel C express CD11b expression as 
percentage of increase over the level 
observed in the case of PMN cultured alone 
without TLR-agonists. All results are 
expressed as mean ± SD (n=6). 
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FIGURE 21. Evaluation of the efficacy of the anti-TLR4 neutralizing mAbs to 
block LPS-mediated effects.  
 
Neutrophils were cultured in regular medium (RPMI supplemented by 10% FBS and 1% 
penicillin/streptomycin) for 20 hours; apoptosis (A), CD16 (B) or CD11b (C) expression were then 
measured (see Materials & Methods). Results were compared to those obtained by adding 100 ng/ml 
LPS with or without 30-minute pre-incubation of neutrophils with 10 g/ml anti-TLR4 mAbs.  
A. Bars represent double negative neutrophils by the Annexin-V/PI method (see Materials & 
Methods), which were considered as viable: their percentage has been reported as percentage of the 
total. Results are expressed as mean ± SD (n=3). B. CD16 and CD11b expression by neutrophils at 
the end of culture. Histogram of relative Fluorescence Intensity (FI) are shown (green lines) and 
compared to their isotype control (red lines). 
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IL-6, IFN- and GM-CSF are primarily responsible for the effects on neutrophil 
survival and CD11b expression mediated by BM-MSC  
We then measured a number of cytokines known to be involved in neutrophil 
survival and activation, including IL-6, IL-8/CXCL8, IFN-, IFN-, IFN-, G-CSF, 
GM-CSF and TNF-; among them, only IL-6 and IL-8/CXCL8 were detectable in 
supernatants harvested from resting BM-MSC cultured for 24 hours (Table 1). The 
latter molecules were present at much higher levels in the supernatants from both 
poly(I:C)- or LPS-stimulated BM-MSC, which both also contained GM-CSF (Table 1). 
Furthermore, while G-CSF, IFN-, IFN- or TNF- were never detectable, IFN- was 
specifically measurable only in poly(I:C)-conditionedmedium (Table 1).  
The presence of IFN- in poly(I:C)-conditioned supernatants was consistent 
with the evidence that TLR3-activated BM-MSC displayed IRF3 dimers and delayed 
STAT1 tyrosine phosphorylation
117
 (Figure 22). On the other hand, no IRF3 or STAT1 
activation occurred in LPS-stimulated BM-MSC (data not shown), which displayed a 
marked activation of both NF-kB and MAP kinase signalling pathways, as expected 
(Figure 22). 
To identify which of the cytokines detected were responsible for neutrophil 
survival and activation under coculture conditions, we subsequently cultured 
neutrophils in the presence of specific neutralizing antibodies against IL-6R, type I IFN-
R, GM-CSF, IL-8/CXCL8 and, as negative controls, G-CSF, IFN- and the related 
isotype matched controls. Both the protective effect on neutrophil survival and the 
induction of higher CD11b expression by untreated MSC were neutralized by the anti-
IL-6R mAbs (data not shown), thus confirming previous findings
110
. By contrast, the 
effects obtained with supernatants from poly(I:C)-treated BM-MSC were almost 
completely neutralized by the simultaneous use of anti-IL-6R, anti-GM-CSF and anti-
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type I IFN-R mAbs, which, if used individually, produced only a limited, partial block 
(Figure 23). Interestingly, the effects of supernatants from LPS-treated BM-MSC were 
significantly reverted, although not completely, by anti-GM-CSF mAbs only, being all 
the other antibodies totally ineffective (Figure 23). Isotype controls did not exert any 
effect under all stimulatory conditions (data not shown). 
 
TABLE 1. Cytokine released by BM-MSC activated by poly(I:C) or LPS. 
Cytokine  no agonist + poly(I:C) + LPS 
IL-6 (ng/ml) 1.3 ± 0.19 22.1 ± 0.62 14.2 ± 0.91 
IL-8/CXCL-8 
(pg/ml) 
48.5 ± 21.2 2873.3 ± 6.3 2846.1 ± 4.4 
IFN-(U/ml) n.d. n.d. n.d. 
IFN-(U/ml) n.d. 5.964 ± 0.2 n.d. 
IFN-(U/ml) n.d. n.d. n.d. 
G-CSF (pg/ml) n.d. n.d. n.d. 
GM-CSF (pg/ml) n.d. 22.27 ± 19.5 21.35 ± 7.3 
TNF- (pg/ml) n.d. n.d. n.d. 
 
IL-6, IL-8/CXCL-8, IFN-, IFN-, IFN-, G-CSF, GM-CSF and TNF- were measured by specific 
ELISA in supernatants harvested from BM-MSC cultured for 24 hours in the absence or presence 
of either 100 g/ml poly(I:C) or 100 ng/ml LPS. Concentration levels are expressed as mean ± SD 
calculated from three sets of experiments performed with BM-MSC expanded from two 
independent healthy donors. n.d. not detectable. 
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FIGURE 22. Activation of the IRF3/STAT1 signaling pathway in poly(I:C)-treated 
BM-MSC. 
 
 
 
 
BM-MSC were  cultured with or without 100 
g/ml poly(I:C) or 100 ng/ml LPS for the 
times indicated, prior to lysis for Western 
Blot analysis.  
Panels A and B show that the stimulation of 
BM-MSC with poly(I:C) results in a 
transient IRF3 dimerization followed by a 
STAT1 tyrosine phosphorylation. Panel C 
shows that stimulation of BM-MSC with LPS 
results in the strong activation of both NF-kB 
and MAP kinase signaling pathways, as 
determined by both p38 and ERK 
phosphorylation, and IkBa degradation, 
respectively. 
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FIGURE 23. Poly(I:C)-activated BM-MSC modulate neutrophil apoptosis and 
CD11b expression through the release and combined action of IL-6, GM-CSF and 
IFN- 
 
A-D. Human neutrophils (PMN) were cultured for 20 hours in supernatants collected from 
poly(I:C)- (A, B) or LPS-stimulated BM-MSC (C, D), in the presence or absence of 10 g/ml 
neutralizing mAbs (or appropriate isotype controls, not shown) directed towards IL-6R, type-I 
IFNR, GM-CSF, G-CSF, IFN- and IL-8/CXCL-8, either alone or in combination. In all conditions 
involving the use of supernatants from LPS-activated BM-MSC (C, D), neutrophils were 
preincubated for 30 minutes with anti-TLR4 mAbs (see Materials & Methods), prior to further 
culture. The degree of apoptosis (A, C) was compared to that observed in PMN culture performed 
in regular medium (see Materials & Methods) without TLR-agonists (apoptotic rate); the expression 
of CD11b (B, D) was measured as geometric mean fluorescence intensity (MFI).  
One representative experiment out of two performed with BM-MSC expanded from two 
independent healthy donors with similar results is depicted.  
Black column: untreated cells; first gray column (X): supernatant-treated cells with no neutralizing 
antibodies. 
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 MSC from thymus, spleen and adipose tissue mimic the effects exerted by BM-MSC 
on neutrophils 
MSC expanded from tissues other than BM (i.e. thymus, spleen and adipose 
tissue) were used to assess whether the TLR3- and TLR4-dependent effects observed 
with BM-MSC were general mechanisms of MSC populations. We found that all types 
of MSC behaved like BM-MSC in terms of either their protective effect on neutrophil 
survival (Figure 24) or immunophenotypic changes (Figure 24), both at resting 
conditions and after TLR3- or TLR4-engagement, at least at the 10:1 PMN:MSC 
coculture ratio. 
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FIGURE 24. MSC from thymus, spleen and adipose tissue mimic the effects that 
BM-MSC exert on neutrophils. 
 
A-C. Neutrophils (PMN) were cocultured for 20 hours at a 10:1 ratio with MSC isolated from 
thymus, spleen and adipose tissue under the same conditions used for BM-MSC and detailed in the 
legend of Figure 1. Survival (A), CD16
high
 fraction (B), and CD11b expression (C) were then 
analyzed by flow cytometry, as detailed in the Materials & Methods and in the legend of Figure 12. 
Results are expressed as mean ± SD (n=3 in all cases).  
P values <0.05 were considered as statistically significant. (*: P<0.05; **: P<0.01; ***: P<0.001). 
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DISCUSSION 
 
In this study, we aimed at exploring under coculture conditions whether TLR-
activated MSC could exert different modulatory effects on neutrophils as compared to 
untreated MSC under coculture conditions. We specifically focused our attention on 
BM-MSC stimulated with poly(I:C) to detect direct BM-MSC-mediated effects towards 
human neutrophils, which do not express TLR3 and do not respond to its ligands
3,112
. 
As control, we analyzed LPS-stimulated neutrophils in coculture with BM-MSC, 
always carefully considering that both BM-MSC and neutrophils express the functional 
TLR4
21-23,111
. 
 
TLRs belong to the pattern recognition receptor (PRR) system that has multiple 
and pleiotropic functions, including the triggering of neutrophils during inflammation
3
. 
Also BM-MSC express several TLRs, capable of activating specific responses
21-
23,103,111
: for instance, while TLR2 maintains BM-MSC in their undifferentiated state, 
without affecting their immunomodulatory properties
97
, both TLR3 and TLR4 influence 
their response to stress and migration
22,111
, as well as regulate their immunomodulatory 
effects towards activated T lymphocytes
21,100,103
. In addition, TLR3 and/or TLR4 
engagement enhances BM-MSC production of IL-1, IL-6 and chemokines, such as IL-
8/CXCL8, IP10/CXCL10, monocyte chemotactic protein (MCP)-1 and CCL5
21-23,97-
98,111
. Finally, TLR3-triggering seems to mediate, under specific conditions, the MSC 
polarization towards the inhibitory phenotype, while TLR4-activation would drive MSC 
towards the opposite pro-inflammatory status
103
. 
It was recently shown that preliminary results about the effects of TLR 
stimulation in neutrophils may have been influenced by the presence of residual 
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“contaminating” cells (mainly monocytes) in PMN preparation obtained after standard 
physical and chemical separation
1
. To avoid this potential bias, several groups have 
added an immunomagnetical depletion step to highly purify neutrophil preparations 
prior to their use in experiments. The potential advantages of this approach has been 
pointed out by some recent publications
7,53,107,118-119
. For instance, previous reports of 
increased survival by eosinophils in response to LPS were demonstrated to actually be 
an indirect effect of LPS on contaminating monocytes, rather than on eosinophils: the 
latter, in fact, do not express TLR4, and can not respond to LPS
118
. At the same time, 
contaminating cells, i.e. monocytes and eosinophils, may partially account also for the 
wide range of constitutive neutrophil apoptosis reported by unrelated studies. When 
analysing a series of factors independently acting on neutrophil apoptosis, Sabroe and 
colleagues
119
 found “LPS addition” and the “presence of a residual percentage (<5%) 
of mononuclear cells” to be synergistically active in enhancing neutrophil survival in a 
CD14-depleted neutrophil preparation
119
. 
 
Herein, using immunomagnetically-depleted, highly purified preparations of 
human neutrophils, we confirmed that in the absence of stimuli BM-MSC significantly 
prolong neutrophil survival in an IL-6-dependent manner, as previously described
110
. 
However, in our experiments such antiapoptotic effect was statistically significant only 
at a 10-times (one log) higher coculture ratio, and lost statistical significance after 44 
hours of coculture. On the other hand, there were no signs of neutrophil activation 
following coculture with resting BM-MSC, as previously described
110
. In particular, we 
did not observe any change either in the levels of neutrophil CD11b expression or in 
their respiratory burst capacity. Furthermore, no cytotoxic effect mediated by 
neutrophils towards the MSC monolayer during coculture was observed. 
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Strikingly, poly(I:C)-activated BM-MSC exerted a significantly greater 
protection of neutrophil from apoptosis than resting BM-MSC; in fact, this effect was 
evident at lower (i.e. 100:1) PMN:BM-MSC ratio and lasted up to 44 hours of 
coculture. In addition, poly(I:C)-activated BM-MSC strongly enhanced neutrophil 
respiratory burst ability and CD11b expression. Similar effects were detected in 
neutrophils cocultured with BM-MSC in the presence of LPS, which was apparently 
even more powerful than poly(I:C) in activating BM-MSC prosurvival effects. 
However, when comparing coculture data with those from PMN-only cultures, this 
advantage resulted partially related to the direct effect of LPS on neutrophil survival and 
immunophenotype. Thus, TLR3-stimulated BM-MSC appeared more efficient than 
TLR4-stimulated BM-MSC, as confirmed also by the comparative experiments of 
neutrophil culture in supernatant from either LPS- or poly(I:C)-triggered BM-MSC.  
MSC obtained from different tissues, such as thymus, spleen and subcutaneous 
adipose tissue, displayed the same effects of BM-MSC in terms of neutrophil survival 
and phenotypic pattern, thus strengthening the concept that TLR3 or TLR4 might 
regulate the interactions in different tissues between stromal cells and recruited 
neutrophils during inflammatory reactions. 
Similar effects were obtained either under Transwell® conditions or by culturing 
neutrophils in supernatants from BM-MSC previously exposed to poly(I:C) or LPS for 
24 hours, thus suggesting that soluble factors were involved. Although IFN-, TNF-
G-CSF, IFN- and IFN- could have been important candidates to mediate the 
observed effects
55
, none of them were detected in any of the BM-MSC-derived 
supernatants; by contrast, high levels of both IL-6 and, to minor extent, IL-8/CXCL-8 
were found in supernatants from resting BM-MSC. These cytokines were even more 
concentrated in poly(I:C)- or LPS-derived supernatants, as previously reported
21-23
. 
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Furthermore, we detected significant amounts of GM-CSF in supernatants from both 
poly(I:C)- and LPS-stimulated BM-MSC, whereas IFN- was found only in samples 
harvested from TLR3-treated BM-MSC. In the latter regard, the activation of IRF3 as 
well as the tyrosine phosphorylation of STAT1 detected in BM-MSC exposed to 
poly(I:C), but not to LPS, is consistent with a specific production of IFN- only after 
TLR3 engagement. Subsequent experiments with specific neutralizing antibodies 
showed that poly(I:C)-stimulated BM-MSC promote neutrophil survival and CD11b 
upregulation almost completely through the combined action of IL-6, IFN- and GM-
CSF, while each single cytokine exerts only a partial effect. By contrast, the effects 
exerted by LPS-stimulated BM-MSC supernatants could be only partially blocked by 
anti-GM-CSF mAbs; in addition, anti-IL-6 mAbs alone were very poorly effective and 
anti-type-I IFN-R, anti-G-CSF, anti-IFN- and anti-IL-8/CXCL-8 mAbs did not exert 
any change. 
The latter data complement and extend the findings recently described by 
Brandau and colleagues
111
, showing that supernatants harvested from parotid-derived 
MSC exposed to LPS for 4 hours contained many different inflammatory cytokines and 
were capable of delaying neutrophil apoptosis. These authors also quantified large 
amounts of G-CSF, TNF- and IFN- and they consequently assumed these cytokines 
as responsible for the observed effects on neutrophils, without however formally 
proving their hypothesis. As mentioned, we were unable to detect G-CSF, TNF- or 
IFN- in supernatants of LPS-stimulated preparations of BM-MSC, even by means of 
high-sensitivity ELISA (see the Materials & Methods section). Accordingly, the 
expression by neutrophils of CD64, a marker well-known to be upregulated after 
exposure to IFN-120, was never increased in neutrophils under any of the coculture 
conditions (data not shown). In addition, there is little data supporting the production of 
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IFN- by BM-MSC expanded from healthy donors, and the production of TNF- by 
MSC is still a controversial issue
22,121
. Nevertheless, in our opinion, these data 
discrepancies could likely reflect a different status of MSC activation due to their 
isolation from healthy rather than pathological microenvironments.  
 
To our knowledge, this is the first study reporting modulatory effects on 
neutrophil survival and activation exerted by MSC via TLR3 activation. As poly(I:C) 
mimicks in vitro double-stranded viral RNA (the natural ligand of TLR3)
117
, a 
functional cross-talk between MSC and neutrophils could occur in vivo in the early 
response to viral infections. In addition, TLR3-activated MSC might influence 
neutrophil behaviour also in other pathological conditions, such as tissue necrosis. In 
fact, endogenous double-stranded RNA may form during tissue necrosis as a result of 
the spontaneous involution of highly repetitive nucleotidic sequences of RNA strands
27-
28
 that, in turn, may activate TLR3 in human dendritic cells
27
, as well as in murine 
neutrophils and macrophages
28
. Thus, tumor-associated MSC and stromal cells could be 
similarly activated through TLR3 in those malignancies characterized by foci of internal 
necrosis, thereby sustaining the recruitment and the activation of tumor-infiltrating 
neutrophils via the production of TLR3-induced IL-8/CXCL-8 and CCL5
21-23,111
. 
Additionally, the demonstration that TLR3 ligation on MSC triggers a cascade 
of events that ultimately favour a prolonged neutrophil survival and enhanced 
respiratory burst ability might also have negative implications for the therapeutic use of 
MSC. For instance, the controversial results obtained by injecting MSC into the 
inflamed joints of patients affected by rheumatoid arthritis
122
 might be explained by the 
shift of MSC towards an unexpected pro-inflammatory, neutrophil-supporting 
phenotype upon in vivo stimulation of their TLR3. In fact, RNA released from necrotic 
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synovial fluid cells has already proved capable of activating fibroblasts from 
rheumatoid arthritis synovial membrane via TLR3
123
: a similar phenomenon could 
occur following stimulation by autoantigens and/or endogenous ligands. 
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CONCLUSIONS 
 
The data we report in this study add new information to the notion of a presumed 
functional MSC polarization induced by TLR3- and TLR4-triggering. In fact, a new 
paradigm for MSC has been recently proposed on the basis of the analogy with the 
functional status of monocytes/macrophages
103
: in particular, that TLR4-primed MSC 
would exhibit a mostly pro-inflammatory profile with increased levels of molecules like 
IL-6, IL-8, or TGF (and thus named as MSC1), whilst TLR3-primed MSC would 
develop the characteristics of immunosuppressive cells producing IL-10, IDO and 
PGE2 (and thus named as MSC2)
103
.  
Our data are partially in contrast with this paradigm, as they show that MSC of 
different tissue origin, in response to TLR3 triggering, may normally become pro-
inflammatory by supporting the survival and function of neutrophils through the release 
of IL-6, IFN- and GM-CSF. Such effects should physiologically evolve into a correct 
immune response aimed to eliminate the danger signals that engage TLR3. However, if 
dysregulated, the process could lead to the development of chronic inflammation and 
autoimmune disorders. Thus, the role of the persistent stimulation of tissue-resident 
MSC via TLR3 and TLR4 under these conditions will have to be clarified by future 
studies. 
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